Alzheimer'S Disease Clinical Trials in Los Angeles, CA

Alzheimer'S Disease Clinical Trials in Los Angeles, CA

View the best 10 alzheimer's disease medical studies in Los Angeles, California. Access promising new therapies by applying to a Los Angeles-based Alzheimer'S Disease clinical trial.

Trials in Los Angeles, California

Here are the top 10 medical studies for alzheimer's disease in Los Angeles, California

Image of Banner Sun Health Research Institute in Sun City, United States.

Escitalopram

Selective Serotonin Reuptake Inhibitor

Recruiting2 awardsPhase 3
This trial will test whether the antidepressant escitalopram is effective and safe for treating agitation in Alzheimer's dementia.
Image of Keck School of Medicine of USC in Los Angeles, United States.

VY7523

Recruiting0 awardsPhase 1 & 2
"This trial is testing a new drug, VY7523, on people with early Alzheimer's Disease. The study will determine the safety and effectiveness of the drug in the brain. The drug will be
Image of University of Alabama in Birmingham in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2 & 3
This trial tests two drugs, lecanemab and E2814, in people with a genetic mutation that causes Alzheimer's disease. Lecanemab helps remove harmful protein clumps from the brain, while E2814 prevents harmful protein tangles from forming. The goal is to see if these drugs can slow down or improve symptoms of Alzheimer's.
Image of Rancho Research Institute, Inc in Downey, United States.

FitMi AD Home Therapy

Procedure

Recruiting1 award
This trial will test a new exercise device to see if it helps people with mild cognitive impairment or mild Alzheimer's. The device tracks movement and records it on a computer.
Image of University of California, San Francisco in San Francisco, United States.

Care Ecosystem

Behavioral Intervention

Recruiting1 award10 criteria
This trial will evaluate how an accessible, team-based dementia care program can improve outcomes for patients, caregivers, and healthcare providers during the pandemic.
Image of Novo Nordisk Investigational Site in Lomita, United States.

Semaglutide

Glucagon-like peptide-1 (GLP-1) receptor agonist

Recruiting1 awardPhase 3
This trial is to test whether the medication semaglutide has a positive effect on early Alzheimer's disease. The study will last for up to 173 weeks, and participants will have 17 clinic visits and 1 phone call with the study doctor. The study includes various tests and scans, and at 10 of the clinic visits participants will have blood samples taken. The trial is only for women.
Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Image of Linfritz Research Institute Inc. in Coral Gables, United States.

Placebo +1 More

Recruiting0 awardsPhase 2 & 3
This trial tests piromelatine, a pill taken before bed, in people with mild Alzheimer's who lack a specific genetic variation. The goal is to see if it can improve brain function and slow down dementia progression.
Image of UCLA Semel Institute for Neuroscience and Behavior in Los Angeles, United States.

Low-Intensity Focused Ultrasound Pulsation (LIFUP)

Device

Recruiting0 awards
This trial is testing whether a new brain stimulation technique can improve memory in people with early Alzheimer's disease.
Image of Collaborative Neuroscience Research, LLC ( Site 0009) in Long Beach, United States.

MK-2214

Recruiting0 awardsPhase 1
This trial is testing a new drug called MK-2214 to see if it is safe and how it behaves in the body. It targets adults with early memory and thinking problems, like mild cognitive impairment or mild-to-moderate Alzheimer's Disease. Researchers want to know if the drug reaches helpful levels in the brain fluid and stays there long enough to potentially help these conditions.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.